MARS treatment in posthepatectomy liver failure.
Posthepatectomy liver failure (PHLF) is a dramatic complication following extensive liver resection or liver resection in a compromised liver, leading to death in 80% of cases. Molecular Adsorbent Recirculating System (MARS) is able to extract water and protein bound toxins out of the blood in liver failure patients. This paper describes the initial experience in the Netherlands using the MARS liver assist device in five patients with PHLF. In all patients, improvement of biochemical parameters was observed during MARS treatment along with clinical improvement in three patients. One patient survived. No clear guidelines for MARS treatment and prognostic factors for outcome after MARS treatment with regard to this patient group are available. In this paper, a MARS treatment regimen for PHLF is suggested based on literature and our own experience.
van de Kerkhove
Maarten-Paul
MP
Departments of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.p.vandekerkhove@amc.uva.nl
de Jong
Koert P
KP
Rijken
Arjen M
AM
de Pont
Anne-Cornélie J M
AC
van Gulik
Thomas M
TM
D000368:Aged; D017809:Fatal Outcome; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D017093:Liver Failure / Q000601:surgery* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000628:therapy; D006435:Renal Dialysis; D016060:Sorption Detoxification